{
  "pmcid": "9577753",
  "sha256": "1346e293092ed649559ac2829a3a9f90814151d54edbcb822260a0580527665b",
  "timestamp_utc": "2025-11-09T23:01:50.263170+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.905121887966807,
    "reading_ease": 29.367309387966827,
    "word_count": 241
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on the Efficacy of Recombinant Human Brain Natriuretic Peptide in Post-CABG Acute Kidney Injury"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "This single-center retrospective study"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients diagnosed with AKI within 4 days post-CABG at The Affiliated Hospital of Qingdao University from January 2016 to December 2020"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were divided into BNP and non-BNP groups based on intravenous rh-BNP administration"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the efficacy of recombinant human brain natriuretic peptide (rh-BNP) in improving renal function in patients with AKI post-CABG"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in serum creatinine levels and urine volume within 4 days post-surgery"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 395 patients were included, with 56 in the BNP group and 339 in the non-BNP group"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "After PSM, 175 patients were analyzed"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The BNP group showed a significant decrease in serum creatinine levels (P<0.001) and increased urine volume (P=0.001) compared to the non-BNP group"
      },
      "Harms": {
        "score": 0,
        "evidence": "No significant difference in diuretic dosage was observed (P=0.852)"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not reported."
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}